Arnold W, Hess G, Dormeyer H H, Gahl G, Hoffmann H G, Knolle J, Schönborn H
Z Gastroenterol. 1979 Oct;17(10):704-12.
This paper describes a "solid-phase"-radioimmunoassay for the demonstration of HBeAg and anti-HBe. The investigations revealed the following results: 1. HBeAg is positive in all patients with acute type B-hepatitis during the acute phase of illness. During the normal course of the disease HBeAg turns to negative followed by an anti-HBe lasting for several months. 2. Cases with a persistent virus B-replication as HBsAg-positive CPH, CAH or patients on hemodialysis are positive for HBeAg in their serum. By means of the fluorescent antibody technique these patients have demonstrable HBcAg and HBeAg in their liver biopsies. 3. Healthy HBsAg carriers are anti-HBe-positive in their serum. In their liver biopsies there are no signs of an on-going virus B-replication (HBsAg and HBeAg negative). 4. The radioimmunological determination of HBeAg and anti-HBe enables us to differentiate between the groups with HBsAg positive acute or chronic hepatitis and the group of healthy HBsAg-carriers.
本文描述了一种用于检测HBeAg和抗-HBe的“固相”放射免疫测定法。研究结果如下:1. 所有急性乙型肝炎患者在疾病急性期HBeAg呈阳性。在疾病的正常病程中,HBeAg转为阴性,随后抗-HBe持续数月。2. 作为HBsAg阳性的慢性持续性肝炎、慢性活动性肝炎患者或接受血液透析的患者,若存在持续的乙肝病毒复制,则其血清中HBeAg呈阳性。通过荧光抗体技术,这些患者的肝活检标本中可检测到HBcAg和HBeAg。3. 健康的HBsAg携带者血清中抗-HBe呈阳性。在他们的肝活检标本中没有正在进行乙肝病毒复制的迹象(HBsAg和HBeAg均为阴性)。4. 对HBeAg和抗-HBe进行放射免疫测定,使我们能够区分HBsAg阳性的急性或慢性肝炎患者组和健康的HBsAg携带者组。